Proteinaceous molecules with stem cell inhibition activity are analogues of LD78 or MIP-1 alpha which have mutations to prevent or reduce multimer formation beyond certain stages (for example a dodecamer). Aggregate formation is therefore inhibited, and the resulting low molecular weight monomers (or oligomers) have improved solution properties leading to enhanced productivity and greater therapeutic utility as stem cell protective agents, which are useful in tumour therapy.
申请公布号
WO9313206(A1)
申请公布日期
1993.07.08
申请号
WO1992GB02390
申请日期
1992.12.23
申请人
BRITISH BIO-TECHNOLOGY LIMITED
发明人
CRAIG, STEWART;HUNTER, MICHAEL, GEORGE;EDWARDS, RICHARD, MARK;CZAPLEWSKI, LLOYD, GEORGE;GILBERT, RICHARD, JAMES